Last updated: October 11, 2023
Sponsor: Ohio State University
Overall Status: Active - Recruiting
Phase
N/A
Condition
N/ATreatment
novel biomarkers of lung disease
Clinical Study ID
NCT02369575
2014H0367
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- any one on lung transplant list
Exclusion
Exclusion Criteria:
- HIV positive
Study Design
Total Participants: 100
Treatment Group(s): 1
Primary Treatment: novel biomarkers of lung disease
Phase:
Study Start date:
February 01, 2015
Estimated Completion Date:
February 28, 2030
Study Description
Connect with a study center
Davis Heart and Lung Research Institute
Columbus, Ohio 43210
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.